136
Participants
Start Date
September 12, 2023
Primary Completion Date
October 12, 2026
Study Completion Date
November 12, 2026
escitalopram
Patients will receive an antidepressant strategy : escitalopram. The strategy will not be modified for a period of 4 weeks. Dosage adjustment and co-prescriptions will be at the discretion of the refeering psychiatrist. After 4 weeks, the strategy can be adapted by the refeering psychiatrist exactly as if the patient had not been included in the trial.
vortioxetine
Patients will receive an antidepressant strategy : vortioxetine. The strategy will not be modified for a period of 4 weeks. Dosage adjustment and co-prescriptions will be at the discretion of the refeering psychiatrist. After 4 weeks, the treatment strategy can be adapted by the refeering psychiatrist exactly as if the patient had not been included in the trial.
NOT_YET_RECRUITING
Groupe hospitalo-universitaire de Grenoble Alpes, La Tronche
NOT_YET_RECRUITING
Centre hospitalier Universitaire de Saint-Etienne, Saint-Priest-en-Jarez
NOT_YET_RECRUITING
Centre hospitalier Universitaire de Lille, Lille
NOT_YET_RECRUITING
Groupe hospitalo-universitaire Assistance Publique, hôpital Pitié Salpêtrière - Hôpitaux de Paris Sorbonne Université, Paris
RECRUITING
- Groupe hospitalo-universitaire Paris Psychiatrie et Neurosciences, Paris
Centre Hospitalier St Anne
OTHER